Victoria C. Wing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Victoria C. Wing has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Tony P. George
4 shared publicationsKristi A. Sacco
Program for Research in Smokers with Mental Illness (PRISM); Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
2 shared publications- Andres M. Lozano
University Health Network and University of Toronto
1 shared publication Caroline E. Wass
1 shared publicationIngrid Bacher
Centre for Addiction and Mental Health (CAMH), Schizophrenia Program; Division of Addiction Psychiatry, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
1 shared publication- Mera S. Barr
Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- 1 May 2013
- Published by Elsevier in Brain Stimulation
- Vol. 6 (3) , 221-230
Brain Stimulation Methods to Treat Tobacco Addiction
- 1 May 2013
- Published by Elsevier in Brain Stimulation
- Vol. 6 (3) , 221-230
Brain Stimulation Methods to Treat Tobacco Addiction
- 1 January 2012
- Published by Elsevier in Addictive Behaviors
- Vol. 37 (1) , 67-72
Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls
- 1 January 2012
- Published by Elsevier in Addictive Behaviors
- Vol. 37 (1) , 67-72
Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls
- 1 August 2011
- Published by Elsevier in Psychiatry Research
- Vol. 188 (3) , 320-326
Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status
- 1 August 2011
- Published by Elsevier in Psychiatry Research
- Vol. 188 (3) , 320-326
Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status
- 20 July 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 219 (3) , 847-857
Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats
Rationale The antidepressant nortriptyline is a second-line pharmacotherapy for smoking cessation. Given that there is limited preclinical data available on the effects of nortriptyline on responses to nicotine, the present study sought to evaluate its effects on the reinforcing, discriminative stimulus (DS) and aversive effects of nicotine in male hooded Lister rats. Methods The effects of nortriptyline (0, 1, 3 and 10 mg/kg, i.p.) on responding under the control of a second order schedule of nicotine (0.03 mg/kg per infusion) intravenous self-administration (IVSA; n = 7), food-maintained responding (n = 6), discrimination of nicotine (0.2 mg/kg, s.c.) from saline in a two-lever procedure controlled by a fixed ratio and variable interval schedule of food reinforcement (n = 12) and on the development of nicotine- and lithium-induced conditioned taste aversions (CTA) (n = 8 per dose of nortriptyline) were examined. Results Nortriptyline (3 mg/kg) reduced responding for nicotine in the drug-free interval in which behaviour was supported by nicotine-associated cues and subsequent intervals in which nicotine was available; however, food-maintained responding was also reduced at the same dose. Nortriptyline (3 mg/kg) blocked the development of a nicotine-induced CTA but not a lithium-induced CTA, indicating that these effects are unlikely to be due to non-specific effects of nortriptyline on taste perception or learning. Lastly, nortriptyline had no effect on the DS properties of nicotine. Conclusions Nortriptyline appears to attenuate the reinforcing and aversive stimulus properties of nicotine, which may mediate its anti-smoking effects. However, the results should be interpreted with caution, as non-specific effects of nortriptyline may have contributed to these findings.
- 20 July 2011
- Published by Springer Nature in Psychopharmacology
- Vol. 219 (3) , 847-857
Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats
Rationale The antidepressant nortriptyline is a second-line pharmacotherapy for smoking cessation. Given that there is limited preclinical data available on the effects of nortriptyline on responses to nicotine, the present study sought to evaluate its effects on the reinforcing, discriminative stimulus (DS) and aversive effects of nicotine in male hooded Lister rats. Methods The effects of nortriptyline (0, 1, 3 and 10 mg/kg, i.p.) on responding under the control of a second order schedule of nicotine (0.03 mg/kg per infusion) intravenous self-administration (IVSA; n = 7), food-maintained responding (n = 6), discrimination of nicotine (0.2 mg/kg, s.c.) from saline in a two-lever procedure controlled by a fixed ratio and variable interval schedule of food reinforcement (n = 12) and on the development of nicotine- and lithium-induced conditioned taste aversions (CTA) (n = 8 per dose of nortriptyline) were examined. Results Nortriptyline (3 mg/kg) reduced responding for nicotine in the drug-free interval in which behaviour was supported by nicotine-associated cues and subsequent intervals in which nicotine was available; however, food-maintained responding was also reduced at the same dose. Nortriptyline (3 mg/kg) blocked the development of a nicotine-induced CTA but not a lithium-induced CTA, indicating that these effects are unlikely to be due to non-specific effects of nortriptyline on taste perception or learning. Lastly, nortriptyline had no effect on the DS properties of nicotine. Conclusions Nortriptyline appears to attenuate the reinforcing and aversive stimulus properties of nicotine, which may mediate its anti-smoking effects. However, the results should be interpreted with caution, as non-specific effects of nortriptyline may have contributed to these findings.
- 13 November 2010
- Published by Elsevier in Schizophrenia Research
- Vol. 128 (1-3) , 171-172
Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia
- 13 November 2010
- Published by Elsevier in Schizophrenia Research
- Vol. 128 (1-3) , 171-172
Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia